Little cigar exposure and oxidative stress markers in adult smokers
Official title: Oxidative Stress and Harmful Constituent Levels Associated With Little Cigars
Run by Milton S. Hershey Medical Center · NCT06310187 · Data updated 2026-11-12
We will test whether using high- or low-oxidant little cigars changes markers of oxidative stress compared with your usual cigarette in adult daily cigarette smokers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Hershey, Pennsylvania) |
| Status | Recruiting |
| Started | March 25, 2026 |
| Main results expected | August 2029 |
| Study ends | August 2029 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT06310187 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults aged 21–65 who smoke at least one cigarette daily, smoke regular filtered cigarettes, have not used little cigars before, and are willing to attend on-site visits in Hershey, PA.
✕Probably not a fit
People who are non-smokers, current little cigar users, pregnant or nursing women, or those with recent serious medical or unstable respiratory, cardiac, renal, hepatic, or severe immune conditions are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, balanced crossover exposure study in adult daily cigarette smokers who have not used little cigars previously. Each participant will complete three exposure conditions: a high-oxidant little cigar, a low-oxidant little cigar, and their usual cigarette, with biological samples collected before and after product use. Samples include exhaled breath condensate, exhaled breath, blood, buccal cells, and saliva collected at specified time points (pre-use, immediately post-use, and at 30 and 60 minutes) and analyzed for oxidant markers such as 8-isoprostanes, 8-OHdG, acrolein adducts, CRP, VOC profiles, nicotine, and metabolomic signatures. The crossover design allows within-subject comparisons of short-term oxidative exposure between product conditions.
Why it matters
Potential benefit: If successful, the results could clarify whether little cigars produce greater or lesser short-term oxidative exposure than cigarettes and help inform clinical, regulatory, and personal decisions about tobacco product risk.
How similar studies have gone: Biomarker studies of cigarettes have reliably measured acute changes in oxidative markers, but direct comparisons specifically involving little cigars are limited, so this approach is partly established but partly novel for little cigars.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 21 - 65 years old 2. Daily cigarette smoker (\>= 1 cigarette per day); 3. Smoke regular, filtered cigarettes or machine rolled cigarettes with a filter 4. No current or past use of Little Cigars 5. All other forms of nicotine must be used \<6 days out of the past 30 days. 6. Able to read and write in English 7. No serious cigarette smoking quit attempt or use of any FDA-approved smoking cessation medication in the prior 30 days 8. No plan to quitting smoking in the next 3 months Exclusion Criteria: 1. Women who are pregnant and/or nursing or trying to become pregnant 2. Unstable or significant medical condition in the past 3 months (e.g., recent heart attack or other serious heart condition, stroke, severe angina) 3. Respiratory diseases (e.g., exacerbations of asthma or Chronic Obstructive Pulmonary Disease (COPD), require oxygen, require oral prednisone), kidney (e.g., dialysis) or liver disease (e.g., cirrhosis), severe immune system disorders (e.g., uncontrolled HIV/AIDS, multiple sclerosis symptoms) or any medical disorder/medication that may affect participant safety or biomarker data 4. Uncontrolled substance abuse or inpatient treatment for that condition in the past 6 months 5. Exhaled Carbon Monoxide (CO) measurement of \>= 17 parts per million
Where it's running
-
Penn State College of Medicine
Hershey, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Joshua Muscat, Ph.D. — Penn State Hershey College of Medicine
- Study coordinator: Joshua Muscat, Ph.D.
- Email: jmuscat@pennstatehealth.psu.edu
- Phone: 7175318521
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
Training to reduce oxidative stress in knee OA
A six-week program compares supervised knee-strengthening training with a daily 6,000-step walking plan to see if it improves pain, function, and blood markers of cellular stress in people with knee osteoarthritis.
-
One extra structured CBT session to help cancer patients quit smoking
This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.
-
Relapse-prevention counseling added to standard care for cancer patients who quit smoking at diagnosis
This trial tests whether adding one structured CBT-based relapse-prevention session helps cancer patients who have remained smoke-free since diagnosis stay abstinent longer.
-
Ashwagandha with resistance training to boost strength and stress markers
This 12-week study tests whether taking ASHWAGANDHA along with regular resistance training helps healthy, trained men see improvements in strength, stress levels, sleep, and cognitive function compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.